TERT and cancer: Mutations at non-coding regions may drive cancer by dysregulating proto-oncogenes and tumor suppressor genes, as exemplified by recent studies demonstrating recurrent point mutations at the TERT promoter in multiple cancer types2,3 and TAL1 enhancer insertions in T-cell acute lymphoblastic leukemia4.